Cefradine injection packed by double-cavity bag and preparation method thereof

A technology of cephradine and injection, which is applied in the field of pharmaceutical composition and its preparation, can solve problems such as inability to airdrop, affect product safety, and time-consuming process of dissolving and diluting, so as to improve effectiveness and safety and prolong product validity period , enhance the effect of environmental adaptability

Inactive Publication Date: 2012-05-02
HUNAN KELUN PHARMA
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, the main preparation forms of this product at home and abroad are: freeze-dried powder injection, aseptic subpackage powder injection, small-volume injection, etc., and the above-mentioned preparations must use appropriate solvents (such as 0.9% chlorine dioxide) before infusion into the patient's body. Sodium chloride injection or 5% glucose injection) can be dissolved or diluted into a solution with a concentration lower than 2mg / ml before intravenous infusion, and the process of dissolving and diluting is relatively time-consuming. Due to the cumbersome dispensing process, rapid intravenous administration is often not possible under certain conditions; the site area of ​​ambulance equipment is narrow and the movement is bumpy, making it difficult to perform dispensing operations or medical errors or accidents such as dispensing errors; air and particle pollution in the ambulance site can easily cause secondary accidents. secondary pollution; therapeutic drugs are packaged in glass bottles, which are easily broken and cannot be airdropped; there are problems such as the matching of therapeutic drugs and carrier infusion quantities and expiration dates in war storage, resulting in the environment and time of the rescue site not reaching the standard for conventional infusion preparation. needs
[0004] Freeze-dried powder injections and sterile subpackaged powder injections sold in the market are all packaged in vials and sealed with butyl rubber stoppers. During the storage and transportation of drugs, when the drug powder comes into contact with the rubber stoppers, the additives in the rubber stoppers may be precipitated or A physical or chemical reaction with the drug powder will lead to unqualified test results of solution clarity and affect the safety of product use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cefradine injection packed by double-cavity bag and preparation method thereof
  • Cefradine injection packed by double-cavity bag and preparation method thereof
  • Cefradine injection packed by double-cavity bag and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0038] The samples prepared in Example 1 were put into glass infusion bottles and double-chamber bags respectively, and the stability investigation was carried out after sterilization. It can be found that the samples were investigated for 6 months in the accelerated test at 40°C and in the long-term test at 25°C for 12 months after sterilization. After one month, each index of the sample of double-chamber bag packaging has no significant change, and the stability is obviously better than that of glass infusion bottle packaging samples. (As shown in Table 1)

[0039] Table 1 Product Stability Investigation Comparison Results

[0040]

[0041]

experiment example 2

[0043] Get 10 cephradine powder injections (in cillin bottle, specification: 0.5g) and 10 bottles of glucose injection (in glass infusion bottle, specification: 100ml: 0.5g) respectively, and transfer cephradine sterile medicine powder into glucose Injection, and make it dissolve completely; Another get 10 bags adopting the double-chamber bag sample that embodiment 1 prepares, open weak welding rod, shake and make cephradine sterile powder dissolve completely, and the operation process is carried out comparative investigation. (As shown in Table 2, the test data is the average value of 10 tests.)

[0044] Table 2

[0045]

[0046] As can be seen from the comparison results, the use of the existing common packaged cefradine preparations is relatively complicated to operate and has high environmental requirements (currently large hospitals generally require operations to be performed on clean operating benches with laminar flow protection), and insoluble particles are likely ...

experiment example 3

[0048] Get respectively 50 cephradine powder injections (penillin bottled, specification: 0.5g) of two manufacturers and 50 bags of double-chamber bag samples prepared in Example 1, and place them under the accelerated test conditions at 40°C to investigate June. Samples all adopt the mode that puts upside down, take out 10 (bags) respectively in accelerating 0, 1, 2, 3, 6 months, cephradine sterile medicine powder is mixed with the solubility of 0.1g / ml with purified water, observe the clarification of solution degree, the results are shown in Table 3:

[0049] table 3

[0050]

[0051] From the investigation data in the above table, it can be known that the product packaged in double-chamber bags has significantly better clarification results of cephradine sterile powder than the products packaged in vials currently on the market, so products packed in double-chamber bags are safer.

[0052] Analyzing the reason, it may be that the composition of the rubber stopper is mo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses cefradine injection packed by a double-cavity bag. A bulk drug of a medicinal compound of the injection comprises components: 0.1-2 part(s) by weight of cefradine in a powder cavity, and glucose injection or sodium chloride injection in a liquid cavity, wherein 100 parts by volume of the glucose injection comprise 4-11 parts by weight of glucose, and 100 parts by volume of the sodium chloride injection comprise 0.8-1 part by weight of sodium chloride. The cefradine injection provided by the invention is packed by adopting the double-cavity bag; through respectively filling cefradine sterile medicinal powder and a solvent (the sodium chloride injection or the glucose injection) in two chambers partitioned and separated by virtual welding; and when the cefradine injection is in use, a medicine bag is only necessary to be extruded, so that a virtual welding isolating strip can be opened, so that the cefradine sterile medicinal powder and the solvent can be quickly dissolved and mixed under a closed sterile condition and form totally medicinal treating mixed liquid which is directly used for a patient.

Description

technical field [0001] The invention relates to a pharmaceutical composition and a preparation method thereof, in particular to a double-cavity bag-packed cephradine injection and a preparation method thereof. Background technique [0002] The chemical name of cephradine is: (6R,7R)-7[(R)-2-amino-2-(1,4-cyclohexenyl)acetamido]-3-methyl-8-oxo-5-sulfur Hetero-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid, a first-generation cephalosporin, is effective against non-penicillinase-producing and penicillinase-producing Staphylococcus aureus, coagulase-negative grape Some strains of gram-positive cocci such as cocci, group A hemolytic streptococcus, pneumococcus pneumoniae and viridans streptococcus have good antibacterial effect. Anaerobic Gram-positive bacteria are more sensitive to this product, and Bacteroides fragilis are resistant to this product. Methicillin-resistant Staphylococcus and Enterococcus are resistant to this product. Cephradine is similar to cephalexin in its...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/08A61K31/545A61P31/04A61J1/10
Inventor 佘佑廷冉良骥田洪伍邹瑰丽万一龙梁隆王利春
Owner HUNAN KELUN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products